Atlas Trials

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Clinical trial NCT04495933 · COMPLETED

Trial details

NCT number
NCT04495933
Sponsor
The University of Queensland
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV2Covid19
Start date
2020-07-13
Primary completion
2024-04-30
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.